HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$10.01
Day range
$9.77 - $10.05
Year range
$2.62 - $11.14
Market cap
609.94M USD
Avg Volume
205.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.74M | 4.56% |
Net income | -16.00M | -17.19% |
Net profit margin | — | — |
Earnings per share | -0.27 | -12.50% |
EBITDA | -18.01M | -8.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 219.84M | -10.44% |
Total assets | 226.20M | -10.27% |
Total liabilities | 13.70M | 37.05% |
Total equity | 212.50M | — |
Shares outstanding | 61.67M | — |
Price to book | 2.84 | — |
Return on assets | -20.74% | — |
Return on capital | -21.86% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.00M | -17.19% |
Cash from operations | -11.97M | -21.36% |
Cash from investing | -11.58M | -732.26% |
Cash from financing | 25.32M | 9,526.24% |
Net change in cash | 1.77M | 122.77% |
Free cash flow | -6.82M | -31.15% |
About
Founded
2017
Headquarters
Website
Employees
54
